Milan Phuyal

Milan Phuyal

Auto-generated profile, based on publicly available information

Milan Phuyal

Pharmaceutical Biotechnology Research Lab, Department of Pharmacy, School of Science, Kathmandu University, Dhulikhel, Kavre, GPO Box 6250, Kathmandu, Nepal

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in International Journal of Chemical Engineering
Verified
Journal Article
Open access
PDF file
MPMilan Phuyal
Milan Phuyal
UButtam Budhathoki
uttam Budhathoki
DBDurga Bista
Durga Bista
SSShailendra Shakya
Shailendra Shakya
RSRajan Shrestha
Rajan Shrestha
ASAshwinee Kumar Shrestha
Ashwinee Kumar Shrestha
The present study is focused on the availability of microbial sources capable of producing xylanase, a hemicelluloses-degrading enzyme with multiple modes of action along with specificity, and their real-world applications. For the accumulation of suitable data, article surfing was carried out using multiple search engines viz. Hinari and PubMed; irrelevant and duplicate articles were discarded and articles were summarized in a narrative way herein. This review article was written aiming to bridge the recent research activities with the commercial activities of xylanase going on around the globe. The readers would be able to acknowledge themselves with the basic idea of the hydrolytic enzyme xylanase, their classification representing their different families, presenting the affinity of different families at the structural level, the sources, and the commercial implications that have been going on alone and in combination. The major hemicellulose, Xylan is digested with the help of combination other enzymes such as alpha-amylase, subtilisin, protease, and endo-1,3(4)-β-glucanase along with xylanase. Xylanase has a diverse applications such as pharmaceutical, food and feed, bakery, paper and pulp, textile, and bio-refinery industries. The objective of this review article is to compile microbial sources of this enzyme and its application for betterment of human kind.

30 July 2023 in Natural Product Communications
Verified
Journal Article
Open access
PPPrem Narayan Paudel
Prem Narayan Paudel
Prabodh SatyalPrabodh Satyal
Prabodh Satyal
William N. SetzerWilliam N. Setzer
William N. Setzer
Suresh AwaleSuresh Awale
Suresh Awale
SWShiro Watanabe
Shiro Watanabe
RGRajendra Gyawali
Rajendra Gyawali
Background: Essential oils (EOs) are one of the most important groups of plant secondary metabolites responsible for their various biological activities. They also have wide applications as natural ingredients in many fields like the food, cosmetic, and medicine industries. This study was conducted to determine the chemical composition, enantiomeric distribution, and in-vitro biological activities of Elsholtzia strobilifera (Benth.) Benth. and E. blanda (Benth.) Benth. essential oils of Lamiaceae from Nepal. Methods: Essential oils obtained from hydro-distillation were analyzed by gas-chromatography mass-spectrometry (GC–MS) for their chemical constituents and the enantiomeric distribution of chiral terpenoids were determined by chiral GC–MS. Microbroth dilution was used to investigate the in-vitro antimicrobial activity, while cytotoxic activities were determined by cell viability using a Cell Counting Kit assay. The DPPH (2,2-diphenyl-1-picrylhydrazyl) radical-scavenging and FRAP (ferric-reducing antioxidant power) assays were used to evaluate the antioxidant activities. Results: A total of 55 compounds were identified in E. strobilifera with pinocarvone (40.7%), β-pinene (10%) and cis-pinocamphone (7.9%) as predominant constituents. While, 41 compounds were identified in the E. blanda EOs, including dihydrotagetone (49.1%), ( Z)-tagetone (15.6%) and ( E)-tagetone (8%) as major components; both essential oils were dominated by oxygenated monoterpenoids. The chiral separation and analyses of 12, E. strobilifera and 7, E. blanda essential oil components were performed, respectively, where (–)-β-caryophyllene and (–)-germacrene D were detected as enantiomerically pure in both oils. Elsholtzia EOs exhibited strong antifungal activity with MIC value of 156.3 µg/mL against Aspergillus niger, whereas, E. strobilifera EO against Staphylococcus epidermidis and E. blanda EO against Staphylococcus aureus showed inhibitory effects with MIC values of 156.3 µg/mL. E. strobilifera EO showed very active in-vitro cytotoxicity against the NIH-3T3 cell line with IC50 of 20.2 µg/mL, whereas E. blanda EO displayed effective cytotoxicity against MCF-7 cell line with IC50 of 33.1 µg/mL. The antioxidant activity of E. strobilifera EO was relatively good with IC50 of 188.8 ± 0.7 µg/mL in DPPH and EC50 value of 348.0 ± 0.1 µg/mL in FRAP, as compared to that of E. blanda EO. Conclusion: Elsholtzia EOs showed prominent biological activities emphasizing their importance as natural ingredients.